First virtual sale of the mylife YpsoPump insulin pump system in India

The challenges because of Covid in India are huge. In some states, there are complete lockdowns and in others, markets and other public places are closed. This makes the news, that the first virtual sale of our mylife YpsoPump insulin pump has taken place in India, even more gratifying.

Ypsomed's sustainability program

Towards a sustainable future

mylife Stories

As a responsible and future-oriented company, sustainability is of crucial importance to us. It is therefore one of our strategic pillars. We are currently further developing our company-wide sustainability program. Our goal is to become carbon-neutral by 2030.

mylife system and Dexcom's CGM

Ypsomed partners with Dexcom

mylife Stories

We have recently entered a partnership with Dexcom to improve your diabetes therapy system. This partnership will make it possible for you to use the Dexcom G6 CGM system as part of the mylife Diabetescare therapy system. Thanks to this integration, you will be able to review mylife YpsoPump insulin data as well as Dexcom’s continuous glucose monitoring data in your mylife App on your smartphone.

Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife App from Ypsomed.